PharVision Advisers’s JPMorgan Chase JPM Stock Holding History

PharVision Advisers’s Portfolio JPM Stock Details JPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,376	Closed	-$330K	–	399
2024 Q4	$330K	Buy	+1,376	New	+$320K	0.28%	127

Other funds holding JPM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PharVision Advisers's JPM Position: Q1 2025 in Review

PharVision Advisers sold out of JPMorgan Chase (JPM) in Q1 2025, closing a stake of 1,376 shares — an estimated $330K sold.

PharVision Advisers first reported a position in JPM in Q4 2024 and held it in 1 quarter. The position peaked at $330K in Q4 2024. 4,675 funds tracked by Wall St. Rank hold JPM as of Q1 2025.

PharVision Advisers reported no remaining JPMorgan Chase position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 1,376 JPMorgan Chase shares in Q1 2025, an estimated $330K.
PharVision Advisers first reported a position in JPMorgan Chase in Q4 2024 and held it in 1 quarter.
PharVision Advisers's JPMorgan Chase position peaked at $330K in Q4 2024.
4,675 funds tracked by Wall St. Rank held JPMorgan Chase as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.